CASI Pharmaceuticals CASIF
OTC CASIF
$0.10 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

CASI Pharmaceuticals (CASIF) Finished Goods (2024 - 2025)

Updated

CASI Pharmaceuticals (CASIF) recorded Finished Goods of $840,000 in Q4 2025, down 84.0% from $5.25 million a year earlier.

Analysis

CASI Pharmaceuticals (CASIF) Finished Goods (2024 - 2025) Analysis & Trends

  • Across earlier years, Finished Goods came in at $5.25 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 CASI Pharmaceuticals 2.06 Mn -18.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 840,000.00
Dec 31, 2024 5.25 Mn
API Access

CASI Pharmaceuticals Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=CASIF&period=max&api_key=YOUR_API_KEY